- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Platysma Bands in Canada
Total 280 results
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Mantle Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Recurrent Lymphoplasmacytic... and other conditionsUnited States, Canada
-
ModernaTX, Inc.WithdrawnRelapsed or Refractory Multiple MyelomaUnited States, Canada
-
CelgeneCompletedMultiple Myeloma | Renal ImpairmentUnited States, Canada
-
TakedaTerminatedRelapsed and/or Refractory Multiple Myeloma (RRMM)United States, Canada
-
Bristol-Myers SquibbRecruitingMultiple MyelomaNorway, United States, Spain, United Kingdom, Canada
-
PETHEMA FoundationJanssen, LP; Adknoma Health ResearchRecruitingMultiple Myeloma | Non-eligible for Autologous Stem Cell Transplantation (ASCT)Spain
-
SanofiActive, not recruitingPlasma Cell MyelomaFrance, United States, Australia, Brazil, Canada, Czechia, Greece, Hungary, Italy, Japan, Korea, Republic of, New Zealand, Russian Federation, Spain, Turkey, United Kingdom
-
Pharmacyclics LLC.CompletedMultiple MyelomaUnited States, Canada
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnLymphomaUnited States, Australia, United Kingdom, Canada, France
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited Kingdom, Spain, Canada, United States, Czechia
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Italy, Canada, France, Germany, Netherlands, Spain
-
CelgeneActive, not recruitingMultiple MyelomaFrance, United States, Canada, Spain, Italy
-
AbbVieGenentech, Inc.; Celgene CorporationWithdrawnMultiple MyelomaUnited States, Australia, Canada, Spain
-
Genentech, Inc.RecruitingMultiple MyelomaUnited States, Canada, Spain, Australia
-
European Society for Blood and Marrow TransplantationCompletedMultiple MyelomaAustria, Denmark, Germany, Finland, Canada, Sweden, Norway, France, Italy, United Kingdom, Turkey
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Germany, Netherlands, Spain
-
Karyopharm Therapeutics IncBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States, Canada
-
Cedars-Sinai Medical CenterEnrolling by invitationAmyloidosis, Immunoglobulin Light-chainUnited States, Canada
-
AstraZenecaRecruitingMultiple MyelomaUnited States, Spain, Australia, Canada, Germany, China, Japan
-
SanofiCompletedPlasma Cell MyelomaFrance, Spain, Greece, Korea, Republic of, United States, Australia, Belgium, Canada, Czechia, Denmark, Germany, Hungary, Italy, Japan, New Zealand, Norway, Poland, Portugal, Russian Federation, Slovakia, Sweden, Taiwan, Turkey, United...
-
Novartis PharmaceuticalsCompletedMultiple MyelomaGermany, Italy, Spain, Canada, United States, Australia
-
Celgene CorporationCompletedMultiple MyelomaUnited States, Canada
-
Gilead SciencesCompletedMultiple MyelomaUnited States, Czechia, Canada
-
PETHEMA FoundationGlaxoSmithKlineRecruitingRELAPSED AND/OR REFRACTORY MULTIPLE MYELOMASpain
-
K36 Therapeutics, Inc.RecruitingMultiple Myeloma | Myeloma | Myeloma MultipleUnited States, France, Spain, Canada
-
CelgeneCompleted
-
PfizerRecruiting
-
PfizerAvailableMultiple MyelomaUnited States, Canada
-
Kiadis PharmaTerminatedLymphoma | Myeloid Leukemia | Myeloproliferative Disorders | Multiple Myeloma | Myelodysplastic Syndrome | Lymphoblastic LeukemiaCanada, Netherlands, Germany, Belgium, United States, Italy, United Kingdom
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States, Canada, United Kingdom, Sweden
-
SanofiRecruitingPlasma Cell MyelomaGermany, United States, Argentina, China, France, Hong Kong, Italy, Japan, Puerto Rico, Spain, Switzerland, United Arab Emirates, United Kingdom, Austria, Belgium, Netherlands, Taiwan
-
PETHEMA FoundationActive, not recruiting
-
Poniard PharmaceuticalsTerminatedMultiple MyelomaUnited States, Canada
-
PETHEMA FoundationCabyc, S.L.Active, not recruiting
-
Human Genome Sciences Inc.CompletedMultiple MyelomaUnited States, Canada, Australia, India
-
AmgenCompletedMultiple Myeloma | Solid TumorsUnited States, Canada
-
Janssen Research & Development, LLCCompleted
-
Janssen-Cilag Ltd.CompletedLymphoma | Leukemia | Multiple Myeloma | Non-Hodgkin | LymphoidArgentina, Colombia, Mexico, Panama, Brazil, Chile, Guatemala
-
Merck Sharp & Dohme LLCWithdrawnMultiple MyelomaUnited States, Canada, France, Israel, Spain, Sweden
-
CelgeneCompletedMultiple MyelomaUnited States, Canada, Belgium, France, Germany, Italy, Japan, Spain
-
PfizerRecruitingMultiple MyelomaUnited States, Canada
-
PETHEMA FoundationCelgene; Pierre Fabre Medicament; Janssen, LPCompleted
-
PfizerCompletedMultiple MyelomaCanada, United States
-
CelgeneCompletedMultiple MyelomaUnited States, Canada, Germany, Spain, Denmark, Netherlands, Finland, Italy
-
Hoffmann-La RocheRecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, Denmark, Spain, Australia, Italy, New Zealand, France, Canada, Germany
-
AmgenCompleted
-
Janssen-Cilag Ltd.CompletedMultiple MyelomaBrazil, Argentina, Mexico, Colombia, Panama
-
Novartis PharmaceuticalsNo longer availableMultiple MyelomaGermany, Austria, Canada, Jordan, Norway, Sweden
-
SanofiActive, not recruitingPlasma Cell MyelomaItaly, Korea, Republic of, Norway, Canada, Spain, Germany, Greece, Lithuania, Sweden, Israel, Hungary, France, Japan, Australia, China, Denmark, Czechia, Turkey, United States, Brazil, Ireland, New Zealand, Poland, United Kingdom